Desmopressin acetate (DDAVP) for preventing and treating acute bleeds during pregnancy in women with congenital bleeding disorders.

07:00 EST 13th February 2019 | BioPortfolio

Summary of "Desmopressin acetate (DDAVP) for preventing and treating acute bleeds during pregnancy in women with congenital bleeding disorders."

Congenital bleeding disorders can cause obstetric haemorrhage during pregnancy, labour and following delivery. Desmopressin acetate (DDAVP) is found to be an effective drug which can reduce the risk of haemorrhage and can also stop bleeding in certain congenital bleeding disorders. Its use in pregnancy has been controversial. Hence beneficial and adverse effects of DDAVP in these groups of pregnant women should be evaluated.This is an update of a Cochrane Review first published in 2013 and updated in 2015.


Journal Details

This article was published in the following journal.

Name: The Cochrane database of systematic reviews
ISSN: 1469-493X
Pages: CD009824


DeepDyve research library

PubMed Articles [9772 Associated PubMed Articles listed on BioPortfolio]

Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia.

Desmopressin is used to reduce bleeding complications for kidney biopsies with azotemia but little is known about desmopressin-induced hyponatremia in these individuals. We aimed to evaluate the impac...

Discovery of Potent, Selective and Short-Acting Peptidic V Receptor Agonists.

The vasopressin analogue desmopressin (dDAVP, 1) is a potent V receptor agonist approved in many countries for the treatment of diabetes insipidus, primary nocturnal enuresis, nocturia, and coagulatio...

Effects of alcohol and acetate on cerebral blood flow: a pilot study.

Acute alcohol produces effects on cerebral metabolism and blood flow (CBF). Alcohol is converted to acetate, which serves as a source of energy for the brain and is an agonist at G protein-coupled rec...

Efficacy and safety of desmopressin in women with nocturia: a systematic review and meta-analysis of randomized controlled trials.

To evaluate the efficacy and safety of desmopressin treatment in women with nocturia.

The contribution of collecting duct NOS1 to the concentrating mechanisms in male and female mice.

The collecting duct (CD) concentrates the urine thereby maintaining body water volume and plasma osmolality within a normal range. The endocrine hormone arginine vasopressin acts in the CD to increase...

Clinical Trials [14190 Associated Clinical Trials listed on BioPortfolio]

Desmopressin Acetate 0.2 mg Tablets, Fasting

The objective of this study was to compare the single-dose relative bioavailability of TEVA and Aventis Pharmaceuticals (DDAVP®) 0.2 mg desmopressin acetate tablets following a 0.8 mg dos...

Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept

The investigators intend to show that DDAVP improves platelet activity from baseline to 30-60 minutes after treatment.

Desmopressin in Cardiac Surgery

Patients undergoing cardiac surgery could develop excessive perioperative bleeding requiring transfusions of blood products. Desmopressin (DDAVP), already used for patients with von Wille...

Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers

The purpose of this study is to determine how female hemophilia A carriers respond to a medication called DDAVP (Desmopressin).

Exercise Versus DDAVP in Patients With Mild Hemophilia A

Individuals with mild hemophilia A (MHA) bleed infrequently but can in the setting of trauma which often is when participating in sports/exercise. Although both exercise and DDAVP (desmopr...

Medical and Biotech [MESH] Definitions

Qualified medical professionals who specialize in preventing and treating disorders of the heart and CARDIOVASCULAR SYSTEM.

The art and science of studying, performing research on, preventing, diagnosing, and treating disease, as well as the maintenance of health.

An enzyme that catalyzes the conversion of acetate esters and water to alcohols and acetate. EC

Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)

A 6-methyl PROGESTERONE acetate with reported glucocorticoid activity and effect on ESTRUS.

Quick Search

DeepDyve research library

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Congenital Diseases
Congenital conditions are those which are present from birth. They include structural deformities or loss of function in organs such as the <!--LGfEGNT2Lhm-->heart, gut or skeletal system. They can be corrected by <!--LGfEGNT2Lhm-->surgery, m...

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Searches Linking to this Article